Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders

NCT02748798 is registered in ClinicalTrials.gov with Thunder Bay Regional Health Research Institute as lead sponsor.

NCT NCT02748798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02748798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders
Lead sponsor
Thunder Bay Regional Health Research Institute
Phase
Phase 1
Overall status
Terminated
Start date
November 10, 2020
Completion date
October 16, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asbestosis, asthma, bronchiectasis, chronic obstructive pulmonary disease, cold virus, cystic fibrosis, emphysema, interstitial lung disease, lung cancer, lung infection, lung resection, lung transplant, mesothelioma, obstructive sleep apnea, pulmonary dysplasia, pulmonary embolism, pulmonary fibrosis, pulmonary hypertension, seasonal allergies